Horizontal competition issue will be solved within 3 years. The restructuring will increase the business concentration/scale/competitiveness of China National Medicines and bring better future growth.
What is covered in the Full Insight:
Restructuring of CNMC and its Impact
CNMC's Dominant Position in the Anesthesia and Psychotropic Drug Business
Business Expansion in Beijing
Future Business Projections for CNMC
Valuation of CNMC
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.